TransMedics Group, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
TransMedics Group, Inc. Q4 2025 Earnings Call Summary - Moby Operational Performance and Strategic Positioning Achieved record performance in Q4 2025, validating management's view that Q3 seasonality was transient and that the U.S. transplant market would recover in the final quarter. Demonstrated market expansion rather than just share-taking, with data showing U.S. liver, heart, and lung volumes grew 25% since 2022 with OCS NOP, but would have declined 1% without it. Attributed strong liver performance to clinical leadership and execution excellence, with OCS Liver now representing 36% of the total U.S. liver transplant volume. Maintained high logistics efficiency, with the company-owned fleet of 22 aircraft covering approximately 80% of NOP missions requiring air transport. Successfully navigated external challenges and competitive disruptions throughout the year, reinforcing the resilience of the OCS NOP integrated service model. Reported a significant income tax be
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- Got $5,000? TransMedics Could Be a High-Tech Organ Transplant Moonshot [Yahoo! Finance]Yahoo! Finance
- TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results [Yahoo! Finance]Yahoo! Finance
- TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial ResultsPR Newswire
- Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? [Yahoo! Finance]Yahoo! Finance
- TransMedics Group (TMDX) had its price target raised by Oppenheimer Holdings, Inc. from $150.00 to $175.00. They now have an "outperform" rating on the stock.MarketBeat
TMDX
Earnings
- 2/24/26 - Beat
TMDX
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- TMDX's page on the SEC website